The findings indicate a significant upregulation of proinflammatory cytokines such as TNF and IL-1β, as well as matrix-degrading enzymes MMP-9 and MMP-13, in MET-stimulated RA-FLS compared to untreated controls (72). This evidence concerns the gene IL1B and rheumatoid arthritis.